JP2021519324A5 - - Google Patents

Info

Publication number
JP2021519324A5
JP2021519324A5 JP2020552322A JP2020552322A JP2021519324A5 JP 2021519324 A5 JP2021519324 A5 JP 2021519324A5 JP 2020552322 A JP2020552322 A JP 2020552322A JP 2020552322 A JP2020552322 A JP 2020552322A JP 2021519324 A5 JP2021519324 A5 JP 2021519324A5
Authority
JP
Japan
Prior art keywords
microscale
bubbles
nanoscale
nanoscale droplets
droplets
Prior art date
Application number
JP2020552322A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021519324A (ja
JPWO2019191518A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/024713 external-priority patent/WO2019191518A1/en
Publication of JP2021519324A publication Critical patent/JP2021519324A/ja
Publication of JP2021519324A5 publication Critical patent/JP2021519324A5/ja
Publication of JPWO2019191518A5 publication Critical patent/JPWO2019191518A5/ja
Priority to JP2024169768A priority Critical patent/JP2025000828A/ja
Pending legal-status Critical Current

Links

JP2020552322A 2018-03-29 2019-03-28 アルツハイマー病を検出および治療する組成物および方法 Pending JP2021519324A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024169768A JP2025000828A (ja) 2018-03-29 2024-09-30 アルツハイマー病を検出および治療する組成物および方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862650239P 2018-03-29 2018-03-29
US62/650,239 2018-03-29
PCT/US2019/024713 WO2019191518A1 (en) 2018-03-29 2019-03-28 Compositions and methods of detecting and treating alzheimer's disease

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024169768A Division JP2025000828A (ja) 2018-03-29 2024-09-30 アルツハイマー病を検出および治療する組成物および方法

Publications (3)

Publication Number Publication Date
JP2021519324A JP2021519324A (ja) 2021-08-10
JP2021519324A5 true JP2021519324A5 (https=) 2022-03-31
JPWO2019191518A5 JPWO2019191518A5 (https=) 2022-03-31

Family

ID=68060802

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020552322A Pending JP2021519324A (ja) 2018-03-29 2019-03-28 アルツハイマー病を検出および治療する組成物および方法
JP2024169768A Pending JP2025000828A (ja) 2018-03-29 2024-09-30 アルツハイマー病を検出および治療する組成物および方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024169768A Pending JP2025000828A (ja) 2018-03-29 2024-09-30 アルツハイマー病を検出および治療する組成物および方法

Country Status (8)

Country Link
US (1) US20210008204A1 (https=)
EP (1) EP3773500A4 (https=)
JP (2) JP2021519324A (https=)
KR (1) KR20210018789A (https=)
CN (2) CN116173238A (https=)
AU (2) AU2019243579B2 (https=)
CA (1) CA3094377A1 (https=)
WO (1) WO2019191518A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2018308088B2 (en) 2017-07-25 2025-05-29 Truebinding, Inc. Treating cancer by blocking the interaction of TIM-3 and its ligand
EP3773500A4 (en) * 2018-03-29 2022-03-16 Microvascular Therapeutics LLC COMPOSITIONS AND METHODS FOR DETECTION AND TREATMENT OF ALZHEIMER'S DISEASE
AU2020214796A1 (en) 2019-01-30 2021-07-29 Truebinding, Inc. Anti-Gal3 antibodies and uses thereof
KR102490837B1 (ko) * 2020-03-19 2023-01-19 포항공과대학교 산학협력단 뇌-혈관 장벽 투과성을 증가시키는 방법
WO2021242776A2 (en) 2020-05-26 2021-12-02 Truebinding, Inc. Methods of treating inflammatory diseases by blocking galectin-3

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2270120A1 (en) * 1996-10-28 1998-05-07 Pal Rongved Improvements in or relating to diagnostic/therapeutic agents
US6090800A (en) * 1997-05-06 2000-07-18 Imarx Pharmaceutical Corp. Lipid soluble steroid prodrugs
US8877236B2 (en) * 2012-06-28 2014-11-04 Universita Degli Studi Di Milano-Bicocca Liposomes active in-vivo on neurodegenerative diseases
US9801959B2 (en) * 2014-06-12 2017-10-31 Microvascuar Therapeutics Llc Phospholipid composition and microbubbles and emulsions formed using same
AU2015330824A1 (en) * 2014-10-08 2017-05-25 Ananth Annapragada MRI imaging of amyloid plaque using liposomes
EP3773500A4 (en) * 2018-03-29 2022-03-16 Microvascular Therapeutics LLC COMPOSITIONS AND METHODS FOR DETECTION AND TREATMENT OF ALZHEIMER'S DISEASE

Similar Documents

Publication Publication Date Title
JP2021519324A5 (https=)
Lee et al. Stimuli‐responsive liposomes for drug delivery
ES2225878T3 (es) Nuevas composiciones de lipidos y materiales estabilizadores.
JP6594909B2 (ja) リン脂質組成物、その凍結乾燥方法および凍結乾燥物
ES2531732T3 (es) Montaje de microvesícula rellena de gas para imagenología de contraste
CN1897978B (zh) 具有用于反差成像的活性组分的充气微囊组件
JP2007515470A5 (https=)
JP7795461B2 (ja) ポリ乳酸塩を含む薬物送達用ナノ粒子組成物製造用キット
JP2002512206A5 (https=)
JP2017517533A5 (https=)
JP2024516152A (ja) 混合カチオン性脂質粒子による組織特異的核酸送達
Antimisiaris et al. Liposomes and drug delivery
JP6803839B2 (ja) 標的化されたガス入りの微小胞の製剤
CN112384202B (zh) 用于检测和治疗阿尔茨海默病的组合物及方法
CN110064057B (zh) 一种透过血脑屏障的载药纳米颗粒的制备及其联合聚焦超声靶向微泡破坏技术的应用
US10010630B2 (en) Gas-filled microvesicles
Amarandi et al. Impact of lipid composition on vesicle protein adsorption: a BSA case study
WO2011135905A1 (ja) 脂質膜構造体
JPWO2019191518A5 (https=)
ES2640060T3 (es) Proceso para producir una partícula fina revestida
ES2698565A1 (es) Procedimiento para la elaboración de nanopartículas lipídicas, y nanopartículas lipídicas con los macrófagos cerebrales como células diana
JP6384863B2 (ja) 脂質膜構造体
US20230226031A1 (en) Formulated and/or Co-Formulated Liposome Compositions Containing Immunogenic Cell Death (ICD) Inducing Prodrugs Useful In The Treatment of Cancer and Methods Thereof
AU2022266501B2 (en) Composition for drug delivery comprising nanoparticles not containing amphiphilic polymer
WO2005092389A1 (ja) 複合粒子および被覆複合粒子